BOLNO PAUL 4
4 · Wave Life Sciences Ltd. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
BOLNO PAUL
DirectorPresident and CEO
Transactions
- Sale
Ordinary Shares
2023-02-16$4.04/sh−29,400$118,776→ 407,425 total - Award
Share Option (right to buy)
2023-02-17+771,000→ 771,000 totalExercise: $4.75Exp: 2033-02-17→ Ordinary Shares (771,000 underlying)
Footnotes (3)
- [F1]On February 16, 2023, the reporting person sold 29,400 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 15, 2023. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $4.03 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.